Company's annual revenue growth of 20.82% outperformed its 3 year CAGR of 6.57%. (Source: Consolidated Financials)
Alpa Labs - Alpa Laboratories Share Price
Alpa Labs - Alpa Labora...
Alpa Labs share price insights
Stock gave a 3 year return of 110.64% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Company has spent less than 1% of its operating revenues towards interest expenses and 12.22% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Stock generated 110.64% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Alpa Laboratories Ltd. share price moved up by 0.04% from its previous close of Rs 108.02. Alpa Laboratories Ltd. stock last traded price is 108.06
Share Price Value Today/Current/Last 108.06 Previous Day 108.02
Key Metrics
PE Ratio (x) | 12.00 | ||||||||||
EPS - TTM (₹) | 9.01 | ||||||||||
MCap (₹ Cr.) | 227.36 | ||||||||||
Sectoral MCap Rank | 91 | ||||||||||
PB Ratio (x) | 1.50 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| -0.23 | ||||||||||
VWAP (₹) | 111.17 | ||||||||||
52W H/L (₹) |
Alpa Labs Share Price Returns
1 Day | 0.04% |
1 Week | 4.59% |
1 Month | 18.49% |
3 Months | 30.82% |
1 Year | 37.05% |
3 Years | 110.64% |
5 Years | 635.1% |
Alpa Labs News & Analysis
Sensex falls! These stocks fell 5% or more in Friday's session
NewsSensex falls! But these stocks rallied over 15% on BSE in today's trade
NewsNSE-BSE bulk deals: Westbridge AIF buys 59.8 lakh shares of AU Small Finance Bank
NewsRevision Of Consolidated Financial Results For The Quarter Ended June,2024.
Announcements
Alpa Labs Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Alpa Labs Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 20.82% outperformed its 3 year CAGR of 6.57%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 12.22% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 26.60 27.57 30.84 35.35 29.87 Total Income Growth (%) -3.51 -10.60 -12.75 18.34 4.90 Total Expenses 21.46 20.61 25.52 29.53 26.82 Total Expenses Growth (%) 4.12 -19.25 -13.59 10.13 30.96 EBIT 5.15 6.97 5.32 5.81 3.05 EBIT Growth (%) -26.10 30.91 -8.47 90.59 -61.85 Profit after Tax (PAT) 5.10 3.55 4.51 5.79 3.03 PAT Growth (%) 43.43 -21.21 -22.11 90.88 -34.78 EBIT Margin (%) 19.35 25.26 17.25 16.45 10.21 Net Profit Margin (%) 19.16 12.89 14.62 16.38 10.15 Basic EPS (₹) 2.42 1.71 2.17 2.75 1.44 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 182.62 167.27 155.24 140.37 121.35 Total Assets Growth (%) 9.18 7.75 10.59 15.67 0.30 Total Liabilities 30.71 32.69 33.51 32.73 20.98 Total Liabilities Growth (%) -6.06 -2.43 2.39 56.00 -7.63 Total Equity 151.91 134.58 121.73 107.64 100.37 Total Equity Growth (%) 12.88 10.55 13.09 7.24 2.13 Current Ratio (x) 5.69 4.67 4.43 3.73 4.59 Total Debt to Equity (x) 0.03 0.02 0.05 0.00 0.00 Contingent Liabilities 0.00 3.25 5.28 5.28 5.75 All figures in Rs Cr, unless mentioned otherwise
Insights
Cash from Operations vs PAT
Operating cash flow of Rs 3.65 cr is 0.22 times compared to the reported net profit of Rs 16.78 cr. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 3.65 8.90 2.17 -1.69 17.78 Net Cash used in Investing Activities -13.34 2.13 -15.61 5.86 -11.17 Net Cash flow from Financing Activities 2.58 -3.79 5.43 0.19 -1.34 Net Cash Flow -7.10 7.24 -8.01 4.35 5.27 Closing Cash & Cash Equivalent 0.06 8.81 2.50 10.52 6.17 Closing Cash & Cash Equivalent Growth (%) -99.32 252.56 -76.24 70.65 963.14 Total Debt/ CFO (x) 1.44 0.26 2.69 -0.01 0.01 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 11.04 9.34 11.57 6.73 1.84 Return on Capital Employed (%) 13.63 11.90 15.97 10.07 3.08 Return on Assets (%) 9.18 7.52 9.07 5.16 1.52 Interest Coverage Ratio (x) 64.02 78.01 97.84 139.46 15.82 Asset Turnover Ratio (x) 0.62 0.58 0.73 69.49 70.84 Price to Earnings (x) 10.47 9.00 10.38 10.50 16.03 Price to Book (x) 1.16 0.84 1.20 0.71 0.30 EV/EBITDA (x) 7.79 6.11 6.98 5.42 3.78 EBITDA Margin (%) 21.14 18.76 19.09 12.39 7.29
Alpa Labs Peer Comparison
Alpa Labs Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 110.64% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 110.64% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 110.64% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 110.64% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Alpa Labs Board Meeting/AGM
Alpa Labs Dividends
- Others
Meeting Date Announced on Purpose Details Aug 13, 2024 Aug 05, 2024 Board Meeting Quarterly Results & A.G.M. May 28, 2024 May 07, 2024 Board Meeting Audited Results Feb 13, 2024 Feb 01, 2024 Board Meeting Quarterly Results Nov 07, 2023 Oct 26, 2023 Board Meeting Quarterly Results Sep 29, 2023 Sep 20, 2023 AGM A.G.M. Dividend announcements are not available.
No other corporate actions details are available.
About Alpa Labs
Alpa Laboratories Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 227.36 Crore) operating in Pharmaceuticals sector. Alpa Laboratories Ltd. key Products/Revenue Segments include Drugs & Pharmaceuticals, Export Incentives, Other Operating Revenue and Sale of services for the year ending 31-Mar-2023. Show More
Executives
Auditors
- MS
Mahendra Singh Chawla
ChairmanPCParesh Chawla
Managing DirectorSSShitul Shah
Whole Time DirectorDBDevendra Baheti
Independent DirectorShow More - C H Padliya & Co.Anuradha Ratnaparkhi & Associates
Industry
Key Indices Listed on
-
Address
33/2, Pigdamber,A.B.Road, Rau,Indore, Madhya Pradesh - 453446
More Details
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.